Alcon has one mission: to provide innovative products that enhance quality of life by helping people see better. The merger with Novartis in 2011 helped us do this by uniting the strengths of Alcon, CIBA VISION and Novartis Ophthalmics into one Alcon eye care business, which is now the second-largest division of Novartis. This enables us to serve our customers through the full life cycle of patient needs across eye diseases, vision conditions and refractive errors.
Novartis Patient Declaration
The Novartis Declaration for Patients spells out our commitments in five areas, from safety to clinical trials.
Alcon’s vision is to be the most trusted leader in eye care. With the Novartis merger in 2011, we were able to expand our global presence to accelerate access to innovative eye care products and partner with eye care professionals around the world. By serving and working with people worldwide, we are building our reputation, while addressing the growing eye care demands of the future.